WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of BIOGEN IDEC INC (BIIB)

Name BIOGEN IDEC INC
Year low 83.83
Year High 133.54
Symbol BIIB
Last trade 132.33
Percentage change 0.00
Volume 0
Media Volume (3m) 1,196,640
PE Ratio 26.00
EPS 5.09
Market Cap 31701
Media fatt 5238
Trend fatt trend fatt graph for BIOGEN IDEC INC
Media net income 1272
Trend net income trend net income for BIOGEN IDEC INC
P / E P / E graph for BIOGEN IDEC INC -  points
EPS EPS graph for BIOGEN IDEC INC - 15 points 15
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for BIOGEN IDEC INC - 0 points 0
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for BIOGEN IDEC INC - 6 points 6
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for BIOGEN IDEC INC - 7 points 7
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for BIOGEN IDEC INC - 13 points 13
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for BIOGEN IDEC INC - 2 points 2
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for BIOGEN IDEC INC - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for BIOGEN IDEC INC - 4 points 4
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for BIOGEN IDEC INC - 4 points 4
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for BIOGEN IDEC INC - 4 points 4
. . graph for BIOGEN IDEC INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for BIOGEN IDEC INC - 0 points 0
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for BIOGEN IDEC INC - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for BIOGEN IDEC INC - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for BIOGEN IDEC INC - 0 points 0
. . graph for BIOGEN IDEC INC - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for BIOGEN IDEC INC - 0 points 0
SINTESE 59

GRAPHS

max price logarithm graph for BIOGEN IDEC INC based on no conditions max volume linear graph for BIOGEN IDEC INC based on no conditions

News

Top High Conviction Healthcare Sector Buys And Sells In Billionaire Steven Cohen's Q1 Filing (May 22 - reuters) 22 Biopharma Stocks With Breakout Potential in 2012 (May 22 - reuters) New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine (May 17 - reuters) New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US (May 14 - reuters) AstraZeneca Is Undervalued (May 10 - reuters) A Diamond in the Rough Among European Pharma (May 10 - reuters) Biogen MS drug application accepted by U.S., EU regulators (May 10 - reuters) Can Teva Win With The Big Pharma Playbook? (May 09 - reuters) US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review (May 09 - reuters) Why Billionaire Carl Icahn Will Target This Substantially Undervalued Biotech (May 08 - reuters) Questcor: Acthar Will Lead Stock To New Highs In 2013 (May 06 - reuters) Tysabri's Looking Good at a Crossroads (May 05 - reuters) Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference (May 03 - reuters) HGSI Could Sink Without New Pipeline Drug Success (May 03 - reuters) Biogen Idec's CEO Discusses Q1 2012 Results - Earnings Call Transcript (May 01 - reuters) Biogen profit below Street view; outlook strong (May 01 - reuters) Biogen Q1 profit falls short of Street view (May 01 - reuters) When Will Spectrum's Run End? (May 01 - reuters) The Week Ahead: Investors Eye Jobs Data; Earnings from Mastercard, Visa, Whole Foods (Apr 30 - reuters) Cramer's Mad Money - 18 Things To Watch In The Coming Week (4/27/12) (Apr 29 - reuters) Spectrum's Undervalued Stock Could Rise If Folotyn Succeeds (Apr 27 - reuters) Noteworthy Insider Trades Wednesday And Thursday In Healthcare, Consumer And Retail (Apr 27 - reuters) New TYSABRI Data Presented at 64th Annual AAN Meeting Highlight Biogen Idec & Elan Commitment to Improving Outcomes in Multiple Sclerosis (Apr 26 - reuters) NEW TYSABRI DATA PRESENTED AT 64TH ANNUAL AAN MEETING HIGHLIGHT BIOGEN IDEC & ELAN COMMITMENT TO IMPROVING OUTCOMES IN MULTIPLE SCLEROSIS (Apr 26 - reuters) Human Genome Sciences Will Soar As Benlysta Gains Traction (Apr 25 - reuters) Biotechnology And Drugs Stocks To Watch For Next Week (Apr 25 - reuters) 3 Healthcare Stocks Looking Undervalued And With Solid Profitability (Apr 25 - reuters) Execution Blurring Novartis' Potential (Apr 24 - reuters) Positive Results from Phase 3 CONFIRM Clinical Trial Show Efficacy and Safety of Oral BG-12 in Multiple Sclerosis (Apr 24 - reuters) 5 Large Cap Stocks With Impressive Bottom Line Profitability And Minimal Debt (Apr 23 - reuters) New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec`s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases (Apr 20 - reuters) Questcor Will Soar If Drugs Can Breach New Markets (Apr 19 - reuters) Novartis: What Will Be Gilenya's Fate? (Apr 19 - reuters) Sanofi Could Plunge This Year On New Legal Pitfalls (Apr 18 - reuters) Spectrum Will Sink Until 2013 (Apr 13 - reuters) HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail (Apr 13 - reuters) The Hard Facts About Questcor (Apr 12 - reuters) Biogen Idec Gearing Up For Major Launches (Apr 11 - reuters) 3 Highly Liquid Biotech Stocks With Positive Receivable Trends (Apr 10 - reuters) Xenoport More Interesting After Washed Out Expectations (Apr 10 - reuters) Biogen Idec to Report First Quarter 2012 Financial Results on May 1, 2012 (Apr 10 - reuters) Spotlight on Biogen (Apr 06 - reuters) Biotech Bull Market Intact: Rayno Biopharmaceutical Portfolio Outperforms (Apr 02 - reuters) Critical Alerts For Exxon Mobil, Biogen Idec, KLA Tencor, VF Corp, and Eldorado Gold By Seven Summits Research (Mar 27 - reuters) 6 Takeover / LBO Targets With Positive Receivable Trends (Mar 20 - reuters) Biogen Idec Takes Option to MAKScientific MS Program (Mar 14 - reuters) Biogen Idec to Present at the Barclays 2012 Global Healthcare Conference (Mar 06 - reuters) Biogen And Samsung Advance Biosimilars Venture (Mar 06 - reuters) Will Novartis Help You Retire Rich? (Feb 29 - reuters) Biogen Idec to Present at the Cowen & Company 32nd Annual Healthcare Conference (Feb 28 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY